GlassScriptPhysician profile
Jonathan L Nathan
NPI 1134449374
$14,435.42
in general payments reported to CMS, 2019-2025
22 companies · $387 in 2025
The $387 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,395 · 2020: $1,817 · 2021: $4,641 · 2022: $1,483 · 2023: $4,374 · 2024: $338 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,918 · Food and Beverage: $1,682 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,918.03 |
| Food and Beverage | $1,682.02 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $9,765.87 | 2019-2023 | |
| Abbvie INC. | $2,919.58 | 2019-2025 | |
| Allergan, INC. | $498.96 | 2021-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $374.10 | 2024-2025 | Clear+Brilliant |
| Motiva USA, LLC | $172.56 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $105.33 | 2020-2025 | Dupixent, Libtayo |
| Smith+Nephew, INC. | $104.42 | 2021-2022 | |
| Galderma Laboratories, L.P. | $70.40 | 2020-2022 | |
| Stryker Corporation | $63.78 | 2020 | |
| Janssen Biotech, INC. | $51.15 | 2022-2023 | Tremfya |
| Misonix INC | $47.71 | 2019 | |
| Sientra, INC. | $40.78 | 2021-2022 | |
| Integra Lifesciences Corporation | $38.27 | 2023 | Durasorb Monofilament Mesh |
| Genzyme Corporation | $24.84 | 2020 | |
| Mission Pharmacal Company | $24.70 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.76 | 2022 | |
| Mentor Worldwide LLC | $22.47 | 2019 | |
| Lilly USA, LLC | $19.34 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.39 | 2020 | |
| Leo Pharma INC. | $17.45 | 2023 | Adbry |
| Mimedx Group, INC. | $17.20 | 2024 | |
| Acacia Pharma INC | $15.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Nathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.